Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration

Seminars in Ophthalmology

Volumn 26, Issue 3, 2011, Pages 216-224

  Du, Hongjun ^a,b   Lim, Siok Lam ^a   Grob, Seanna ^a   Zhang, Kang ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

cell replacement; disease models; photoreceptors; retinal pigment epithelium

Indexed keywords

ANTIOXIDANT; CRE RECOMBINASE; EPSTEIN BARR VIRUS ANTIGEN 1; KRUPPEL LIKE FACTOR 4; LIN28A PROTEIN; LIPOFUSCIN; LYSOSOME ENZYME; MELANIN; MICRORNA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

AGE; ALLOGENEIC STEM CELL TRANSPLANTATION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLINDNESS; BONE MARROW CELL; BRUCH MEMBRANE; CARCINOGENESIS; CD34 SELECTION; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL TRANSFORMATION; CHOROID CAPILLARY LAYER; DISEASE COURSE; DISEASE MODEL; DNA MODIFICATION; DRUSEN; EMBRYONIC STEM CELL; EXPRESSION VECTOR; EXUDATIVE MACULAR DEGENERATION; FLUORESCENCE ACTIVATED CELL SORTING; GENE INTERACTION; GENETIC TRANSDUCTION; GEOGRAPHIC ATROPHY; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; KERATINOCYTE; LENTIVIRINAE; LIVER CELL; MELANOCYTE; NEURAL STEM CELL; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATIVE STRESS; PATHOGENESIS; PHOTORECEPTOR; PHOTORECEPTOR TRANSPLANTATION; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RETINA CELL; RETINA CONE; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA ROD; RETROVIRUS; SAFETY; SCID MOUSE; SKIN FIBROBLAST; STARGARDT DISEASE; STEM CELL TRANSPLANTATION; TERATOMA; TRANSGENE; VIRUS REACTIVATION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREORETINOPATHY;

ANIMALS; DISEASE MODELS, ANIMAL; GEOGRAPHIC ATROPHY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACULAR DEGENERATION; STEM CELL TRANSPLANTATION;

EID: 79957611753     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2011.577498     Document Type: Article

References (98)

1. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: Etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. May-Jun 2003;48(3):257-293. (Pubitemid 36553096)
2. Gonzales CR. Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: An exploratory analysis. Retina. Oct-Nov 2005;25(7):815-827. (Pubitemid 41456570)
3. Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: A systematic review and economic evaluation. Health Technol Assess. May 2008;12(16):iii-iv, ix-201.
4. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Twoyear results of the ANCHOR study. Ophthalmology. Jan 2009;116(1):57-65 e55.
5. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. Jun 12 2008;358(24):2606-2617.
6. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. Prog Retin Eye Res. Sep 2007;26(5):516-554. (Pubitemid 47302351)
7. Ma Z, Han L, Wang C, et al. Autologous transplantation of retinal pigment epithelium-Bruch's membrane complex for hemorrhagic age-related macular degeneration. Invest Ophthalmol Vis Sci. Jun 2009;50(6):2975-2981.
8. Caramoy A, Liakopoulos S, Menrath E, Kirchhof B. Autologous translocation of choroid and retinal pigment epithelium in geographic atrophy: Long-term functional and anatomical outcome. Br J Ophthalmol. Aug;94(8):1040-1044.
9. Joeres S, Llacer H, Heussen FM, Weiss C, Kirchhof B, Joussen AM. Optical coherence tomography on autologous translocation of choroid and retinal pigment epithelium in age-related macular degeneration. Eye (Lond). Jun 2008;22(6):782-789. (Pubitemid 351850514)
10. Morgan JI, Dubra A, Wolfe R, Merigan WH, Williams DR. In vivo autofluorescence imaging of the human and macaque retinal pigment epithelial cell mosaic. Invest Ophthalmol Vis Sci. Mar 2009;50(3):1350-1359.
11. Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol. Dec 1994;232(12):707-716.
12. Tezel TH, Del Priore LV, Berger AS, Kaplan HJ. Adult retinal pigment epithelial transplantation in exudative age-related macular degeneration. Am J Ophthalmol. Apr 2007;143(4):584-595.
13. Lund RD, Wang S, Klimanskaya I, et al. Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells. Fall 2006;8(3):189-199. (Pubitemid 44735173)
14. Osakada F, Ikeda H, Mandai M, et al. Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol. Feb 2008;26(2):215-224. (Pubitemid 351225958)
15. Idelson M, Alper R, Obolensky A, et al. Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell. Oct 2 2009;5(4):396-408.
16. Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. Sep 2009;27(9):2126-2135.
17. Wang NK, Tosi J, Kasanuki JM, et al. Transplantation of reprogrammed embryonic stem cells improves visual function in a mouse model for retinitis pigmentosa. Transplantation. Apr 27 2010;89(8):911-919.
18. Lamba DA, Gust J, Reh TA. Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice. Cell Stem Cell. Jan 9 2009;4(1):73-79.
19. Van Hoffelen SJ, Young MJ, Shatos MA, Sakaguchi DS. Incorporation of murine brain progenitor cells into the developing mammalian retina. Invest Ophthalmol Vis Sci. Jan 2003;44(1):426-434. (Pubitemid 36134305)
20. Mellough CB, Cui Q, Harvey AR. Treatment of adult neural progenitor cells prior to transplantation affects graft survival and integration in a neonatal and adult rat model of selective retinal ganglion cell depletion. Restor Neurol Neurosci. 2007;25(2):177-190. (Pubitemid 47290445)
21. Merhi-Soussi F, Angenieux B, Canola K, et al. High yield of cells committed to the photoreceptor fate from expanded mouse retinal stem cells. Stem Cells. Sep 2006;24(9):2060-2070. (Pubitemid 44477131)
22. Klassen H, Kiilgaard JF, Zahir T, et al. Progenitor cells from the porcine neural retina express photoreceptor markers after transplantation to the subretinal space of allorecipients. Stem Cells. May 2007;25(5):1222-1230. (Pubitemid 46684882)
23. Tomita M, Mori T, Maruyama K, et al. A comparison of neural differentiation and retinal transplantation with bone marrow-derived cells and retinal progenitor cells. Stem Cells. Oct 2006;24(10):2270-2278. (Pubitemid 44527480)
24. Inoue Y, Iriyama A, Ueno S, et al. Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration. Exp Eye Res. Aug 2007;85(2):234-241. (Pubitemid 47087799)
25. Castanheira P, Torquetti L, Nehemy MB, Goes AM. Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats. Arq Bras Oftalmol. Sep-Oct 2008;71(5):644-650.
26. Thumann G, Salz AK, Walter P, Johnen S. Preservation of photoreceptors in dystrophic RCS rats following allo- and xenotransplantation of IPE cells. Graefes Arch Clin Exp Ophthalmol. Mar 2009;247(3):363-369.
27. Ghosh F, Wong F, Johansson K, Bruun A, Petters RM. Transplantation of full-thickness retina in the rhodopsin transgenic pig. Retina. Feb 2004;24(1):98-109. (Pubitemid 38240847)
28. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: A prospective trial. Invest Ophthalmol Vis Sci. Nov 2004;45(11):4151-4160. (Pubitemid 39411174)
29. van Meurs JC, ter Averst E, Hofland LJ, et al. Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes. Br J Ophthalmol. Jan 2004;88(1):110-113. (Pubitemid 38091375)
30. Joussen AM, Heussen FM, Joeres S, et al. Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol. Jul 2006;142(1):17-30.
31. Aisenbrey S, Lafaut BA, Szurman P, et al. Iris pigment epithelial translocation in the treatment of exudative macular degeneration: A 3-year follow-up. Arch Ophthalmol. Feb 2006;124(2):183-188. (Pubitemid 43247067)
32. Degenring RF, Cordes A, Schrage NF. Autologous translocation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration. Acta Ophthalmol. 2009;50(6):2975-2981.
33. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. Aug 25 2006;126(4):663-676. (Pubitemid 44233629)
34. Comyn O, Lee E, MacLaren RE. Induced pluripotent stem cell therapies for retinal disease. Curr Opin Neurol. Feb 2010;23(1):4-9.
35. Jin ZB, Okamoto S, Mandai M, Takahashi M. Induced pluripotent stem cells for retinal degenerative diseases: a new perspective on the challenges. J Genet. Dec 2009;88(4):417-424.
36. Parameswaran S, Balasubramanian S, Babai N, et al. Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: Therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration. Stem Cells. Apr 2010;28(4):695-703.
37. Carr AJ, Vugler AA, Hikita ST, et al. Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One. 2009;4(12):e8152.
38. Buchholz DE, Hikita ST, Rowland TJ, et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells. Oct 2009;27(10):2427-2434.
39. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. Apr 2004;122(4):564-572. (Pubitemid 38456293)
40. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. Feb 1995;102(2):205-210.
41. Klein R, Knudtson MD, Lee KE, Gangnon RE, Klein BE. Ageperiod- cohort effect on the incidence of age-related macular degeneration: The Beaver Dam Eye Study. Ophthalmology. Sep 2008;115(9):1460-1467.
42. Klein R, Klein BE, Lee KE, Cruickshanks KJ, Gangnon RE. Changes in visual acuity in a population over a 15-year period: The Beaver Dam Eye Study. Am J Ophthalmol. Oct 2006;142(4):539-549.
43. Adijanto J, Banzon T, Jalickee S, Wang NS, Miller SS. CO2- induced ion and fluid transport in human retinal pigment epithelium. J Gen Physiol. Jun 2009;133(6):603-622.
44. Krohne TU, Stratmann NK, Kopitz J, Holz FG. Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Exp Eye Res. Mar;90(3):465-471.
45. Khandhadia S, Lotery A. Oxidation and age-related macular degeneration: Insights from molecular biology. Expert Rev Mol Med. Oct 2010; 12:e34.
46. Krohne TU, Kaemmerer E, Holz FG, Kopitz J. Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action. Exp Eye Res. Feb 2010;90(2):261-266.
47. Kaneko H, Dridi S, Tarallo V, et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature. Mar 2011;471(7338):325- 330.
48. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. Jan 1997;104(1):7-21. (Pubitemid 27081937)
49. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE. Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. Apr 2001;42(5):1051-1056. (Pubitemid 32289803)
50. Boulton ME. [RPE transplantation: the challenges and the future]. Ophthalmologe. Sep 2004;101(9):877-881. (Pubitemid 39256513)
51. Coffey PJ, Girman S, Wang SM, et al. Long-term preservation of cortically dependent visual function in RCS rats by transplantation. Nat Neurosci. Jan 2002;5(1):53-56. (Pubitemid 34038783)
52. Carr AJ, Vugler A, Lawrence J, et al. Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis. 2009;15:283-295.
53. Wang S, Girman S, Lu B, et al. Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci. Jul 2008;49(7):3201-3206.
54. Francis PJ, Wang S, Zhang Y, et al. Subretinal transplantation of forebrain progenitor cells in nonhuman primates: survival and intact retinal function. Invest Ophthalmol Vis Sci. Jul 2009;50(7):3425-3431.
55. Osakada F, Takahashi M. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: Targeting the Wnt pathway and transplantation therapy as strategies for retinal repair. J Pharmacol Sci. Feb 2009;109(2):168-173.
56. Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci U S A. Aug 2006;103(34):12769-12774. (Pubitemid 44298636)
57. Binder S, Stolba U, Krebs I, et al. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: A pilot study. Am J Ophthalmol. Feb 2002;133(2):215-225. (Pubitemid 34072050)
58. Kanuga N, Winton HL, Beauchene L, et al. Characterization of genetically modified human retinal pigment epithelial cells developed for in vitro and transplantation studies. Invest Ophthalmol Vis Sci. Feb 2002;43(2):546-555. (Pubitemid 34113241)
59. Thumann G, Bartz-Schmidt KU, Heimann K, Schraermeyer U. Phagocytosis of rod outer segments by human iris pigment epithelial cells in vitro. Graefes Arch Clin Exp Ophthalmol. Oct 1998;236(10):753-757. (Pubitemid 28458675)
60. Abe T, Yoshida M, Yoshioka Y, et al. Iris pigment epithelial cell transplantation for degenerative retinal diseases. Prog Retin Eye Res. May 2007;26(3):302-321. (Pubitemid 46498799)
61. Schraermeyer U, Kayatz P, Thumann G, et al. Transplantation of iris pigment epithelium into the choroid slows down the degeneration of photoreceptors in the RCS rat. Graefes Arch Clin Exp Ophthalmol. Dec 2000;238(12):979-984. (Pubitemid 32000760)
62. Cai H, Shin MC, Tezel TH, Kaplan HJ, Del Priore LV. Use of iris pigment epithelium to replace retinal pigment epithelium in age-related macular degeneration: A gene expression analysis. Arch Ophthalmol. Sep 2006;124(9):1276-1285. (Pubitemid 44379862)
63. Osakada F, Ikeda H, Sasai Y, Takahashi M. Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc. 2009;4(6):811-824.
64. Aramant RB, Seiler MJ, Ball SL. Successful cotransplantation of intact sheets of fetal retina with retinal pigment epithelium. Invest Ophthalmol Vis Sci. Jun 1999;40(7):1557-1564. (Pubitemid 29252347)
65. Radtke ND, Aramant RB, Seiler MJ, Petry HM, Pidwell D. Vision change after sheet transplant of fetal retina with retinal pigment epithelium to a patient with retinitis pigmentosa. Arch Ophthalmol. Aug 2004;122(8):1159-1165. (Pubitemid 39031131)
66. Radtke ND, Aramant RB, Petry HM, Green PT, Pidwell DJ, Seiler MJ. Vision improvement in retinal degeneration patients by implantation of retina together with retinal pigment epithelium. Am J Ophthalmol. Aug 2008;146(2):172-182.
67. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. Nov 30 2007;131(5):861-872. (Pubitemid 350138099)
68. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. Dec 21 2007;318(5858):1917- 1920.
69. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. Aug 29 2008;321(5893):1218-1221.
70. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell. Sep 5 2008;134(5):877-886.
71. Balasubramanian S, Babai N, Chaudhuri A, et al. Non cell-autonomous reprogramming of adult ocular progenitors: Generation of pluripotent stem cells without exogenous transcription factors. Stem Cells. Dec 2009;27(12):3053-3062.
72. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science. Nov 7 2008;322(5903):949-953.
73. Markoulaki S, Hanna J, Beard C, et al. Transgenic mice with defined combinations of drug-inducible reprogramming factors. Nat Biotechnol. Feb 2009;27(2):169-171.
74. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. Jan 16 2003;348(3):255-256. (Pubitemid 36077924)
75. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. Oct 17 2003;302(5644):415-419. (Pubitemid 37296260)
76. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. Aug 1 2008;321(5889):699-702.
77. Soldner F, Hockemeyer D, Beard C, et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. Mar 6 2009;136(5):964-977.
78. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. May 8 2009;324(5928):797-801.
79. Woltjen K, Michael IP, Mohseni P, et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. Apr 9 2009;458(7239):766-770.
80. Kim D, Kim CH, Moon JI, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. Jun 5 2009;4(6):472-476.
81. Jia F, Wilson KD, Sun N, et al. A nonviral minicircle vector for deriving human iPS cells. Nat Methods. Mar 2010;7(3):197-199.
82. Huangfu D, Maehr R, Guo W, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. Jul 2008;26(7):795-797. (Pubitemid 351961456)
83. Li W, Ding S. Generation of novel rat and human pluripotent stem cells by reprogramming and chemical approaches. Methods Mol Biol. 2010;636:293-300.
84. Lin T, Ambasudhan R, Yuan X, et al. A chemical platform for improved induction of human iPSCs. Nat Methods. Oct 18 2009;6(11):805-808
85. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. Jun 5 2008;2(6):525-528. (Pubitemid 351729222)
86. Zhu S, Li W, Zhou H, et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell. Dec 3;7(6):651-655.
87. Zhao Y, Yin X, Qin H, et al. Two supporting factors greatly improve the efficiency of human iPSC generation. Cell Stem Cell. Nov 6 2008;3(5):475-479.
88. Wilson KD, Venkatasubrahmanyam S, Jia F, Sun N, Butte AJ, Wu JC. MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev. Jun 2009;18(5):749-758.
89. Eminli S, Foudi A, Stadtfeld M, et al. Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet. Sep 2009;41(9):968-976.
90. Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. Aug 2009;27(8):743-745.
91. Sun N, Longaker MT, Wu JC. Human iPS cell-based therapy: Considerations before clinical applications. Cell Cycle. Mar 1 2010;9(5):880-885.
92. Ikeda H, Osakada F, Watanabe K, et al. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci USA. Aug 9 2005;102(32): 11331-11336. (Pubitemid 41153820)
93. Meyer JS, Shearer RL, Capowski EE, et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA. Sep 29 2009;106(39):16698-16703.
94. Hirami Y, Osakada F, Takahashi K, et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett. Jul 24 2009;458(3):126-131.
95. Osakada F, Jin ZB, Hirami Y, et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci. Sep 1 2009;122(Pt 17):3169-3179.
96. Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA. Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One. 2010;5(1):e8763.
97. Jiang C, Klassen H, Zhang X, Young M. Laser injury promotes migration and integration of retinal progenitor cells into host retina. Mol Vis. 2010;16:983-990.
98. Lu B, Wang S, Girman S, McGill T, Ragaglia V, Lund R. Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration. Exp Eye Res. Sep 2010;91(3):449-455.